Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
Oracle Corporation's published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $457.4B | |
|---|---|---|
| Revenue (ttm) | 71.8B | |
| Net income (ttm) | 18.7B | |
| EPS (ttm) | $6.38 | |
| Shares out | 3B | |
| P/E (trailing) | 22.6x | |
| P/E (forward) | 19.1x | |
| Dividend | $2.00 (1.39%) | |
| Volume | 71,261,003 | |
| Beta | 1.77 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-05-31 | 2023-05-31 | 2024-05-31 | 2025-05-31 | 2026-05-31 | Trend |
| Revenue | $42.44B | $49.95B | $52.96B | $57.40B | $67.36B | +12.2% |
| Gross profit | $33.56B | $36.39B | $37.82B | $40.47B | $43.92B | +7.0% |
| Operating income | $10.93B | $13.09B | $15.35B | $17.68B | $20.61B | +17.2% |
| Net income | $6.72B | $8.50B | $10.47B | $12.44B | $17.09B | +26.3% |
| EPS (diluted) | $2.41 | $3.07 | $3.71 | $4.34 | $5.83 | +24.7% |
| EBITDA | $13.53B | $18.74B | $21.39B | $23.91B | $32.14B | +24.2% |
| R&D | $7.22B | $8.62B | $8.92B | $9.86B | $10.27B | +9.2% |
| SG&A | $1.32B | $1.58B | $1.55B | $1.60B | $1.62B | +5.3% |
Recent company headlines from major financial publishers.
Confirmation requires revenue delivery and improving cash generation by FY2028. Persistent cash use would disconfirm the path.
The path gains support if the dominant cloud-and-software business expands and free cash flow turns positive after FY2026’s cash use.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 7.2% | $230 | $241 | $254 | $269 | $289 |
| 8.2% | $203 | $210 | $219 | $229 | $241 |
| 9.2% | $182 | $187 | $193 | $200 | $208 |
| 10.2% | $165 | $169 | $173 | $178 | $184 |
| 11.2% | $151 | $154 | $157 | $161 | $165 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |